Drugs / dexamethazone
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00733382 | Feb → Dec 2008 | migraine disorder | Shiraz University of Medical Sciences | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06527651 | Jun → Jul 2024 | osteoarthritis, knee, perceptual disorders | Ankara City Hospital Bilkent | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06692010 Background | Dec 2024 → Dec 2026 expected | — | Assiut University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dexamethazone | “4 mg Dexamethazone” NCT06692010 ↗ |
| Route | Other | “injection form, 8 miligram, injected once” NCT00733382 ↗ |